Status:

COMPLETED

A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP

Lead Sponsor:

Virginia Commonwealth University

Collaborating Sponsors:

United States Department of Defense

Uniformed Services University of the Health Sciences

Conditions:

Pneumonia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence ...

Detailed Description

Pneumonia is the leading cause of death from nosocomial infections. Intubation and mechanical ventilation greatly increase the risk of ventilator associated pneumonia (VAP) which is highest in trauma,...

Eligibility Criteria

Inclusion

  • trauma victim
  • endotracheal intubation within the past 12 hours
  • mechanical ventilation

Exclusion

  • diagnosis of pneumonia at the time of intubation
  • previous endotracheal tube placement in the last 48 hours
  • burn injuries

Key Trial Info

Start Date :

August 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2008

Estimated Enrollment :

156 Patients enrolled

Trial Details

Trial ID

NCT00248300

Start Date

August 1 2005

End Date

August 1 2008

Last Update

November 11 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Virginia Commonwealth University School of Nursing

Richmond, Virginia, United States, 23298

A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP | DecenTrialz